NCT03057366View on ClinicalTrials.gov

A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 11, 2017

Primary Completion Date

February 8, 2018

Study Completion Date

November 5, 2018

Conditions
Advanced Solid Tumors, Neoplasms, Advanced Solid
Interventions
DRUG

Pevonedistat

Pevonedistat intravenous infusion.

DRUG

[14C]-Pevonedistat

\[14C\]-Pevonedistat intravenous infusion.

DRUG

Docetaxel

Docetaxel intravenous infusion.

DRUG

Carboplatin

Carboplatin intravenous infusion.

DRUG

Paclitaxel

Paclitaxel intravenous infusion.

Trial Locations (2)

1062

Magyar Honvédség Egészségügyi Központ Onkológiai osztály, Budapest

1076

PRA Magyarország Kft. Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY